G1 Therapeutics, Inc.

GTHX | NASDAQ | 2 Sledující

$7.16

0.14%

$0.01

Sledovat

Overview Metrics Financials

Breakdown	12/31/2023 USD	12/31/2022 USD	12/31/2021 USD
Total revenue	82,511 +60.84%	51,301 +62.98%	31,476 -
Cost of revenue	7,195 +91.97%	3,748 +85.91%	2,016 -
Gross profit	75,316 +58.38%	47,553 +61.42%	29,460 -
Operating expense	114,843 -37.49%	183,731 +6.87%	171,917 -
Operating income	-39,527 +70.97%	-136,178 +4.41%	-142,457 -
Pretax Income	-44,852 +69.25%	-145,859 +1.06%	-147,427 -
Tax Provision	3,115 +83.24%	1,700 +83.78%	925 -
Net income	-47,967 +67.49%	-147,559 +0.53%	-148,352 -
EPS	-0.93 +72.49%	-3.38 +4.52%	-3.54 -
Diluted EPS	-0.93 +72.49%	-3.38 +4.52%	-3.54 -
Average Shares	51,733 +18.58%	43,626 +4.01%	41,943 -
Diluted Average Shares	51,733 +18.58%	43,626 +4.01%	41,943 -
EBIT	-34,814 +74.29%	-135,427 +5.14%	-142,760 -
EBITDA	-39,014 +71.08%	-134,897 +5.31%	-142,457 -

Soubory cookie používáme ke zlepšení prohlížení na webu.